debt cap
valu usd unless otherwis note
start year
view view strong organ growth quarter unit
intern busi perform particularli well margin
improv although expect signific margin expans near-
term momentum mm acquir revenu far
growth outlook good believ current
valuat captur expect near-term improv
rais estim price target rais ep
estim respect mostli
reflect higher revenu assumpt also bump
price target still equat
revis ep ebitda/shar forecast respect
mainli consist expect arthur gallagh report
adjust ep vs modestli better
estim match consensu expect slight upsid
estim corpor segment
item note gallagh continu realiz fairli broad-bas strength
across brokerag segment organ growth provid
outlook organ growth segment
gallagh see notabl top-lin momentum
evidenc australia/new zealand organ growth uk
canada expect posit trend persist
year manag bit construct rate
note price exposur unit boost organ growth rate
point risk manag unit also gener strong organ
growth compani guid organ growth
rise claim count increas demand carrier handl claim
strong intern growth driver expect increment
margin expans unit meantim gallagh
announc seven acquisit year mm annual
revenu includ larger acquisit uk-bas stackhous poland
addit gallagh term sheet sign agre upon
mm annual revenu
posit strong start year good momentum
solid organ growth across segment quarter
encourag outlook recent quarterli dividend increas
month around
neg guidanc risk manag margin impli
increment margin improv deal environ
competit multipl paid rise higher forecast loss
corpor segment
price prior trade day market close estimate unless otherwis note
arthur gallagh continu experi solid organ
growth busi brokerag unit perform
well economi start improv price outlook
bit brighter risk manag continu gener good
growth expect continu despit
solid organ growth expect expect limit
margin expans anticip compani
activ program focu small bolt-on deal
rather larger-s deal compani also big
opportun grow intern year ahead
acquisit organ gallagh name
gain traction outsid sector perform
rate reflect view share fairli valu
current multipl given subdu margin outlook
 remain part stori deal environ
remain competit due privat equiti involv
expect compani still manag find suitabl
acquisit opportun next year
solid organ growth new busi gener
domest insur busi core middle-market
custom continu good risk manag
unit start show improv top-lin trend
pay-out ratio yield remain fairli appeal provid
downsid protect stock
upside/risk invest thesi
integr recent acquisit although compani
announc new big deal recent
still integr risk associ particularli
margins/expens control despit compani
better job manag cost recent year think
improv margin difficult current level
without signific revenu gain given rise cost
environ broker
program present uncertainti ep pictur
leav compani subject chang coal price ir
tax treatment synfuel credit lower visibl
profit invest
bloomberg capit market estim upside/downside/target
base case incorpor adjust oper ep
estim assum brokerag commiss
fee growth roughli top-lin forecast assum
good contribut slight price increas
solid organ growth trend unit assum
adjust ebitdac margin factor
modest margin expans reason margin recent
acquisit posit impact tax reform
price target approxim ep
upsid scenario assum commiss fee
growth could driven better-than-
 solid intern growth scenario
factor addit basi point margin improv
result good cost contain better-than-
anticip oper leverag revenu gain upsid
scenario incorpor multipl ep
adjust ebitdac forecast
downsid scenario assum commiss fee
growth reflect challeng econom
new busi environ flat insur price
assum basi point margin contract rel
expect result higher-than-expect cost
weaker margin recent acquisit less favor
oper leverag lower rel sale gain downsid
scenario assum multipl approxim
ep adjust ebitdac forecast
takeaway quarter
brokerag unit deliv anoth quarter solid top-lin growth gallagh
continu realiz fairli broad-bas strength across brokerag segment
organ growth third consecut quarter organ growth mark
unit domest off-set organ growth
domest retail benefit gallagh see strong top-lin
momentum evidenc australia/new zealand organ growth uk
canada manag bit construct rate environ
posit commentari rate increas year one region
rate compar stronger australia new zealand rate
nice benefit gallagh rate exposur unit posit influenc
organ growth rate point similar manag guid organ
growth brokerag segment around exud confid new
busi growth stay good year initi guidanc brokerag ebitdac
margin expans similar around basi point
think signific margin expans tougher come due difficult comp rise
organ growth risk manag segment risk manag organ
revenu growth pace tick upper end
manag guidanc think compani continu see strong
growth new zealand/australia intern growth carrier
appetit outsid claim handl also appear strengthen claim count
risen year unfold particularli gener liabil worker
compens class consist improv economi natur
tailwind risk manag claim busi initi manag guidanc
risk manag unit produc organ growth compar around
organ growth thought guidanc ebitdac margin
littl disappoint given expect top-lin lift although could prove
strong start year way plenti
activ acquisit mm annual revenu year fast
start compani announc seven acquisit year mm annual
revenu recent acquisit stackhous poland larger deal compani
one expand penetr uk market
evid strong pace isnt slow anytim soon manag
note gallagh current term sheet sign agre upon mm
annual revenu gallagh increas borrow million fund
 growth compani capac spend billion
 exist resourc view gallagh compet well deal even
signific competit pe player although deal multipl arguabl rise
rais estim price target
rais ep estim
respect mostli reflect higher revenu assumpt also bump
price target still equat revis ep
ebitda/shar forecast respect
key highlight arthur gallagh report adjust ep vs
modestli better estim match consensu expect
slight upsid estim corpor segment ebitdac margin touch
ahead assumpt off-set slightli lower-than-expect brokerag
segment revenu compar estim invest incom gain realiz sale
book busi total million better million assumpt
net restructur cost incur result
total brokerag commiss fee revenu grew million
forecast brokerag supplement conting commiss came short expect
million vs million estim million million impact
higher cat activ client organ growth brokerag segment better
estim organ growth manag guid organ growth
brokerag segment ebitdac margin expand basi point
basi point better estim adjust compens ratio percentag
revenu fell basi point oper expens ratio percentag
revenu rose basi point
risk manag total fee revenu million match
estim risk manag organ revenu growth upper end
manag guidanc forecast adjust compens
expens ratio percentag total revenu rose basi point
oper expens ratio percentag total revenu fell basi point
risk manag segment adjust ebitdac margin improv basi point
better forecast
forecastvariancebrokerag servic segment total commiss organ growth adjust ebitdac manag segment total organ growth adjust ebitdac segment ep total commiss total adjust oper result pro-forma present reflect insurance/nonlif
corpor segment produc adjust ep loss versu essenti
break-even result last year forecast loss dollar term
adjust loss million vs estim loss million total corpor
segment revenu grew million compani provid guidanc
corpor segment produc loss million heavili weight toward
bigger loss also reflect higher interest expens due recent borrow
gallagh announc acquisit mm annual revenu
particularli activ pace month decemb total million
acquir revenu brokerag segment remaind risk
gallagh weight averag ebitdac multipl paid acquisit total
gallagh cash cash equival end year million nearli
unchang rel end septemb million year ago
total debt outstand increas billion billion end
septemb debt/cap ratio end year addit million new
borrow announc
price target approxim ep ebitdac/shar forecast
price target support sector perform rate stock trade premium
peer time stock trade closer peer valuat think in-lin multipl
appropri due subdu margin expans prospect rel certain peer
less credit ep driven clean coal earn
risk rate price target
believ signific risk price target rate includ continu industri
wide price pressur higher expect employe cost unexpect invest loss
unanticip cost relat recent acquisit
arthur gallagh intern insur brokerag risk manag servic
firm headquart itasca illinoi compani core busi entail provid insur
brokerag risk manag altern risk transfer insur small- medium-
size compani compani oper major market also oper
servic capabl countri compani third-largest insur
broker fourth-largest world
deprec amort expens
deprec amort expens
compani report capit market estim
